Once dysregulated, these miRNAs exhibit their effect on CML using diverse functions, including regulating BCR::ABL1 transcripts, modulating the CML LSC, activating or suppressing pathways implicit in CML, and regulating drug transporters. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.